If a particularly important and digitally well-connected HCP tweeted about your new data today, and assuming 50% of their HCP followers retweeted that, and assuming 50% of those followers’ follower
If a particularly important and digitally well-connected HCP tweeted about your new data today, and assuming 50% of their HCP followers retweeted that, and assuming 50% of those followers’
In amongst the big clinical trial readouts at ASCO, a new research project made its official debut with the ambitious goal of mapping cancer cells’ interactions with their
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas